News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
42 Results
Type
Article (10)
Company Profile (1)
Press Release (31)
Section
Business (20)
Deals (2)
Job Trends (4)
News (21)
Tag
Alliances (1)
Artificial intelligence (1)
Bankruptcy (1)
Best Places to Work (4)
Biotechnology (1)
Cancer (2)
CAR-T (1)
Cell therapy (2)
Clinical research (3)
Collaboration (1)
Data (2)
Events (3)
Executive appointments (1)
FDA (2)
Funding (3)
Gene editing (1)
Generative AI (1)
Gene therapy (1)
Healthcare (2)
Layoffs (2)
Mergers & acquisitions (2)
Neurodegenerative disease (1)
Neuroscience (1)
NextGen: Class of 2026 (3)
Non-profit (1)
Patient recruitment (1)
People (12)
Phase 1 (3)
Phase 2 (3)
Preclinical (2)
Rare diseases (3)
Regulatory (3)
Rett syndrome (1)
Series A (2)
Sickle cell disease (2)
Startups (4)
Date
Last 7 days (1)
Last 30 days (2)
Last 365 days (12)
2026 (2)
2025 (10)
2024 (8)
2023 (6)
2022 (6)
2021 (8)
2020 (2)
Location
California (2)
Europe (3)
Massachusetts (13)
Northern California (1)
United States (14)
42 Results for "ensoma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Profluent Bio Announces Strategic Collaboration with Ensoma to Develop AI-Designed Base Editors for In Vivo Hematopoietic Stem Cell Therapies
December 10, 2025
·
2 min read
Press Releases
Ensoma Announces First Patient Dosed in Phase 1/2 Clinical Trial of EN-374 for Treatment of X-CGD
December 2, 2025
·
4 min read
Press Releases
Ensoma Announces Clearance of U.K. Clinical Trial Authorization Application for EN-374, First In Vivo HSC-Directed Gene Insertion Therapy
December 11, 2025
·
3 min read
Press Releases
Ensoma to Present New Preclinical Data at the Society for Immunotherapy of Cancer Annual Meeting
October 6, 2025
·
1 min read
Press Releases
Ensoma Presents Preclinical Data Demonstrating Potential of In Vivo, HSC-derived CAR-M, NK, and T Platform for Solid Tumors at SITC 2025
November 5, 2025
·
3 min read
Press Releases
Ensoma Announces $53 Million Financing to Support Key Clinical Milestones for EN-374 and Continued Development of In Vivo Hematopoietic Stem Cell Engineering Pipeline
September 23, 2025
·
3 min read
Press Releases
Ensoma Announces FDA Clearance of IND Application for First In Vivo HSC-Directed Gene Insertion Therapy
May 12, 2025
·
4 min read
Business
Ensoma Appoints Accomplished Company Builder and Product Developer, Jim Burns, Ph.D., as Chief Executive Officer
Ensoma announced the appointment of Jim Burns, Ph.D., as chief executive officer and a member of the company’s board of directors.
May 13, 2024
·
2 min read
Press Releases
Ensoma to Present Preclinical Data and Manufacturing Advancements for In Vivo HSC Engineering Platform to Treat Cancer, Immune Disorders and Genetic Diseases at ASGCT 28th Annual Meeting
April 29, 2025
·
5 min read
Press Releases
Ensoma Receives Rare Pediatric Disease and Orphan Drug Designations for EN-374 for Treatment of Chronic Granulomatous Disease
February 13, 2025
·
3 min read
1 of 5
Next
